Gallentes, Lyca L.

HRN: 19-25-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2024
CEFUROXIME 1.5GM (VIAL)
11/07/2024
11/13/2024
IV
1.5g
Q8
D&C
Waiting Final Action 
11/08/2024
CEFUROXIME 500MG (TAB)
11/08/2024
11/14/2024
ORAL
500mg
2 Times A Day
S/P Completion Curettage
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: